to the editor: It was good to see the review article1 of basal cell and squamous cell carcinomas. Please note that, since this article was written, imiquimod 5% cream (Aldara) has received approval by the U.S. Food and Drug Administration for the treatment of some types of actinic keratoses and basal cell cancers. It is specifically indicated for the treatment of biopsy-confirmed, primary superficial basal cell carcinoma in immunocompetent adults, with a maximum tumor diameter of 2 cm.2
Letters to the Editor
Imiquimod to Treat Basal Cell and Squamous Cell Carcinomas
CURTIS D. KELLER, M.D.,
3M Pharmaceuticals, St. Paul, MN 55144
American Family Physician. 2005;72(1):41.
Email letter submissions to afplet@aafp.org. Letters should be fewer than 400 words and limited to six references, one table or figure, and three authors. Letters submitted for publication in AFP must not be submitted to any other publication. Letters may be edited to meet style and space requirements.
This series is coordinated by Kenny Lin, MD, MPH, deputy editor.
